FULCRUM THERAPEUTICS
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases. The company develops a proprietary product engine that is employed to identify and validate cellular drug targets that can modulate gene expression. Its product candidate, losmapimod, is a small molecule that was developed for the treatment of FSHD, a muscle-wasting disorder that leads to physical impairment and disability. It is focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases. Founded in 2016, the company is based in Cambridge, Massachusetts, United States.
FULCRUM THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.fulcrumtx.com
Total Employee:
101+
Status:
Active
Contact:
(617)651-8851
Total Funding:
478.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Amazon IPv6 Google Google Cloud Amazon Virginia Region Microsoft
Similar Organizations
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Raze Therapeutics
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Motus Therapeutics
Motus Therapeutics is a biotechnology company developing peptide therapeutics for the treatment of metabolic diseases.
NovelMed Therapeutics
NovelMed Therapeutics is a biotechnology company developing novel therapies for orphan and non-orphan diseases.
Northwest Biotherapeutics
Northwest Biotherapeutics is a biotechnology company focused on developing and commercializing immunotherapy products to treat cancer.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Vesigen Therapeutics
Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products.
Versartis
Versartis is a biotechnology company developing therapeutic proteins for the treatment of endocrine disorders.
Morphic Therapeutic
Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.
Mistral Therapeutics
Mistral Therapeutics operates as a biotechnology company developing medicines to treat fibrosis.
Viridian Therapeutics
Viridian Therapeutics is a biotechnology company that offers treatments for patients suffering from diseases.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Magenta Therapeutics
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.
Lyra Therapeutics
Lyra Therapeutics is a clinical-stage company developing medicines to treat ear, nose, and throat diseases.
Alethia BioTherapeutics
Alethia BioTherapeutics is a biotechnology company developing monoclonal antibody-based therapeutics for cancer-associated diseases.
Aeglea BioTherapeutics
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
ANA Therapeutics
ANA Therapeutics is a biotech company that is developing a novel coronavirus vaccine intended to save human lives.
Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Arcion Therapeutics
Arcion Therapeutics is a biotechnology company developing treatments for chronic pain.
Aerpio Pharmaceuticals
Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.
Aditxt Therapeutics
Aditxt Therapeutics is a biotechnology company that develops a novel nucleic acid-based technology.
Alector
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Encoded Therapeutics
Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Expansion Therapeutics
Expansion Therapeutics is a biotechnology company focused on developing transformative oral medicines for severe RNA-mediated diseases.
EnClear Therapies
EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease
Elixirgen Therapeutics
Elixirgen Therapeutics is a biotechnology company focused on the development of therapies for genetic diseases and vaccines.
Beam Therapeutics
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Bilayer Therapeutics
Bilayer Therapeutics is a biotech company that develops a first-in-class therapeutic for constipation and other diseases of the colon.
Bio-Path Holdings
Bio-Path Holdings is a biotechnology company developing therapeutic products for the liposomal delivery of nucleic acids in cancer patients.
Fulgent Therapeutics
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
Forge Therapeutics
Forge Therapeutics is a biotechnology company developing novel medicines by combining bio-inorganic with medicinal chemistry.
Flare Therapeutics
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
Foundation Medicine
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Tempest Therapeutics
Tempest Therapeutics is a biotechnology company that focuses on small molecule therapeutics that modulate anti-tumor pathways.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Treadwell Therapeutics
Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
Jnana Therapeutics
Jnana Therapeutics is a biotechnology company developing therapies that transform the lives of patients.
QED Therapeutics
QED Therapeutics is a biotechnology company focused on precision medicine for FGFR-driven disorders.
QurAlis
QurAlis is a operator of a biotechnology company intended to discover and develop potential precision therapeutics for ALS.
Sarepta Therapeutics
Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.
Sonnet BioTherapeutics
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.
Siva Therapeutics
Siva Therapeutics is a biotechnology company developing nanotechnology approaches for treating cancer.
Synthorx
Synthorx is a biotechnology company using synthetic biology to synthesize solutions.
SynerGene Therapeutics
SynerGene Therapeutics is a biotechnology company with focuses on developing gene-based nanotech cancer therapeutics and diagnostics.
Synlogic
Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Decibel Therapeutics
Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Harpoon Therapeutics
Harpoon Therapeutics is a clinical-stage immunotherapy company developing novel T cell engagers (TriTACs) for the treatment of cancer.
IMMvention Therapeutix
IMMvention Therapeutix is a biotechnology company developing novel small molecule pan-inflammasome inhibitors for inflammatory diseases.
Innovative Cellular Therapeutics
Innovative Cellular Therapeutics is a Shanghai-based biotechnology company engaged in research and development of cell therapy.
InVivo Therapeutics
InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.
Intellia Therapeutics
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Gyroscope Therapeutics
Gyroscope Therapeutics is a clinical-stage gene therapy company focused on developing therapies and treating diseases of the eye.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Oncternal Therapeutics
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Larimar Therapeutics
Larimar Therapeutics is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases.
Color
Color is a complete platform for healthcare delivery.
CytomX Therapeutics
CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies.
Casma Therapeutics
Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines.
CAMP4 Therapeutics
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Celularity
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.
Centauri Therapeutics
Centauri Therapeutics is a UK-based biotechnology company focused on the discovery and development of life threatening diseases.
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Cidara Therapeutics
Cidara Therapeutics is a biotechnology company that specializes in the fields of healthcare and therapeutics.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Convelo Therapeutics
Convelo Therapeutics is committed to developing medicines to regenerate myelin around nerve cells and restoring function.
CureGenetics
Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
ProQR Therapeutics
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.
Pendulum Therapeutics
Pendulum Therapeutics is a biotechnology company improving health through products targeting the microbiome.
Pinteon Therapeutics
Pinteon Therapeutics is a biotechnology company advancing clinical studies of a novel antibody.
Providence Therapeutics
Providence Therapeutics is a biotechnology company that develops a personalized mRNA cancer vaccine designed to treat ovarian cancer.
Current Employees Featured
Jeannie T. Lee Scientific Co-Founder @ Fulcrum Therapeutics
Scientific Co-Founder
2016-07-01
Robert J. Gould President and Chief Executive Officer @ Fulcrum Therapeutics
President and Chief Executive Officer
2016-07-01
Angela M. Cacace Vice President @ Fulcrum Therapeutics
Vice President
2016-01-01
Walter Kowtoniuk Director, Strategy and Operations @ Fulcrum Therapeutics
Director, Strategy and Operations
2016-05-01
Judith Dunn interim CMO @ Fulcrum Therapeutics
interim CMO
2022-07-01
Danny Reinberg Co-Founder @ Fulcrum Therapeutics
Co-Founder
Esther Rajavelu CFO @ Fulcrum Therapeutics
CFO
2022-01-01
Bradley Bernstein Co-Founder @ Fulcrum Therapeutics
Co-Founder
Robert Gould Director @ Fulcrum Therapeutics
Director
2016-06-01
Rudolf Jaenisch Co-Founder @ Fulcrum Therapeutics
Co-Founder
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Fulcrum Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Fulcrum Therapeutics
Casdin Capital
Casdin Capital investment in Post-IPO Equity - Fulcrum Therapeutics
Boxer Capital
Boxer Capital investment in Post-IPO Equity - Fulcrum Therapeutics
Alyeska Investment Group
Alyeska Investment Group investment in Post-IPO Equity - Fulcrum Therapeutics
Foresite Capital
Foresite Capital investment in Post-IPO Equity - Fulcrum Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Post-IPO Equity - Fulcrum Therapeutics
Monashee Investment Management
Monashee Investment Management investment in Post-IPO Equity - Fulcrum Therapeutics
6 Dimensions Capital
6 Dimensions Capital investment in Series B - Fulcrum Therapeutics
Sanofi
Sanofi investment in Series B - Fulcrum Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-11 | Fulcrum Therapeutics Announces Departure of Chief Medical Officer |
Official Site Inspections
http://www.fulcrumtx.com Semrush global rank: 3.07 M Semrush visits lastest month: 5.25 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Fulcrum Therapeutics"
Fulcrum Therapeutics - Crunchbase Company Profile
Organization. Fulcrum Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
Careers - Fulcrum Therapeutics
Fulcrum was proud to sponsor the 2025 Sickle Cell Disease Virtual Policy Forum. Hosted by Sick Cells and Sickle Cell Community Consortium, this powerful event brought together sickle cell …See details»
Fulcrum Therapeutics - LinkedIn
Fulcrum Therapeutics | 12,369 followers on LinkedIn. We are a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high ...See details»
Fulcrum Therapeutics® Reports Recent Business Highlights and …
The increase of $1.5 million was primarily due to increased employee-compensation costs to support the growth of our research and development organization. G&A Expenses: General …See details»
MyoKardia and Fulcrum Therapeutics Announce Multi-Target …
Jul 21, 2020 Potential diseases associated with such undisclosed targets are expected to share common characteristics with indications currently being pursued by MyoKardia: strong and …See details»
Fulcrum Therapeutics Announces Recent Business Highlights and …
Nov 13, 2024 website at www.fulcrumtx.com or by clicking here . Following the live webcast, an archived replay will also be available. About Fulcrum Therapeutics Fulcrum Therapeutics is a …See details»
Working At Fulcrum Therapeutics: Company Overview and Culture …
Mar 14, 2024 www.fulcrumtx.com. Organization Type. Public. Social Media. Fulcrum Therapectics to develop new medicines to deliver a new future for patients and their families …See details»
Fulcrum Therapeutics - Craft
Oct 29, 2024 Fulcrum Therapeutics has 5 employees at their 1 location and $80 m in annual revenue in FY 2024. See insights on Fulcrum Therapeutics including office locations, …See details»
Fulcrum Therapeutics
Modulating gene expression to treat the root cause of genetically defined diseases. Learn more about our pipeline and our culture.See details»
Mel Hayes • Fulcrum Therapeutics
Sep 7, 2021 Mel joined Fulcrum in September 2021 as Chief Commercial Officer and was subsequently appointed to the role of Chief Operating Officer in June 2022. Mel was appointed to Executive Vice President, Patient Experience, in …See details»
Fulcrum Therapeutics, Inc. - Cruelty Free Investing
Company Website: https://www.fulcrumtx.com Contact: ir@fulcrumtx.com ©2025 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization …See details»
Fulcrum Therapeutics, Inc. (Fulcrum Therapeutics, Inc.) - 药物管线_ …
Fragile X Syndrome (FXS) is the most common genetic form of intellectual disability caused by a CGG repeat expansion in the 5''-UTR of the Fragile X mental retardation gene FMR1, …See details»
Christopher Moxham, Ph.D. • Fulcrum Therapeutics
Feb 3, 2021 Chris Moxham, Ph.D. joined Fulcrum in January 2019 as senior vice president of Discovery Research before being promoted to chief scientific officer in January 2021. He has …See details»
Fulcrum Therapeutics Announces Recent Business Highlights and …
22 hours ago For more information, visit www.fulcrumtx.com and follow us on Twitter/X (@FulcrumTx) and LinkedIn. About Pociredir Pociredir is an investigational oral small …See details»
About Us - The Fulcrum Group
About The Fulcrum Group Learn about the Fulcrum Group’s history, approach to delivering services, impact on Texas communities, and more. We hope that when you read more on …See details»
Fulcrum Therapeutics to Host First Quarter 2025 Financial Results ...
Apr 24, 2025 Fulcrum uses proprietary technology to identify drug targets that can modulate gene expression to treat the known root cause of gene mis-expression. For more information, …See details»
Plans advance for huge Exxon plastics plant on Texas coast | The …
1 day ago Exxon, which reported nearly $34 billion in profits in 2024, is seeking a 50% reduction in its school district property taxes for 10 years, beginning in 2031, when the project would …See details»
Pipeline - Fulcrum Therapeutics
Each of our product candidates is a small-molecule therapeutic that aims to treat the root cause of a genetically defined rare disease.See details»
Our Approach - Fulcrum Therapeutics
Our product engine in action: Addressing the root cause of FSHD. FSHD, a rare, progressive and disabling disorder, is caused by aberrant expression of the DUX4 gene in skeletal muscle …See details»
Fulcrum Therapeutics to Host Third Quarter 2024 Financial Results ...
Nov 6, 2024 Fulcrum uses proprietary technology to identify drug targets that can modulate gene expression to treat the known root cause of gene mis-expression. For more information, visit …See details»